Option grant gives Clene (NASDAQ: CLNN) director 5,372 share rights

Rhea-AI Filing Summary

Clene Inc. director David J. Matlin received a stock option grant covering 5,372 shares of Common Stock. The option was granted on February 19, 2026 under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share and vests immediately upon grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATLIN DAVID J

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$4.73	02/19/2026		A		5,372		(1)	02/18/2036	common stock	5,372	$0	5,372	D

Explanation of Responses:

1. This option was granted on February 19, 2026 as an option for 5,372 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clene (CLNN) report for David J. Matlin?

Clene reported that director David J. Matlin received a stock option grant for 5,372 shares of Common Stock. The option was awarded under the Amended 2020 Stock Plan and vests immediately, giving him the right to purchase shares at a fixed exercise price.

How many Clene (CLNN) shares are covered by the new option grant?

The new option grant covers 5,372 shares of Clene Common Stock. This represents the total number of shares underlying the stock option reported, all of which vest immediately and become exercisable according to the terms described in the filing footnote.

What is the exercise price of David J. Matlin’s Clene (CLNN) stock options?

The exercise price for David J. Matlin’s Clene stock options is $4.73 per share. This is the price at which he can purchase each of the 5,372 underlying shares once he chooses to exercise the fully vested option.

When were the new Clene (CLNN) stock options granted to David J. Matlin?

The stock options were granted on February 19, 2026. This grant date is specified in the footnote and marks when the 5,372-share option became effective under the Clene Inc. Amended 2020 Stock Plan.

Do the Clene (CLNN) stock options granted to David J. Matlin vest over time?

No, the options vest immediately upon grant according to the disclosure. This means all 5,372 option shares are fully vested on the February 19, 2026 grant date and are exercisable at the stated exercise price of $4.73 per share.

Is the reported Clene (CLNN) stock option grant held directly by David J. Matlin?

Yes, the filing indicates direct ownership of the option by David J. Matlin. The ownership type is coded as direct, and there is no footnote shifting voting or investment authority to another entity such as a trust or LLC.